Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

ladybug biotech week lupus

News and Trends 14 May 2016

What Happened this Week? Lupus fight, CRO, Plant charger

1. Today is World Lupus Day! Meet the people who are fighting this Rare disease 2. This UK Company told us how they Optimise Drug Development and turn a Profit 3. Meeting the startup which uses Plants to charge your Smartphone 4. This Dutch Gene Therapy is on the shelf and seems to Work. But nobody is […]

May 14, 2016 - 1 minutemin - By Philip Hemme

abbvie bms empliciti multiple myeloma cancer immunooncology ema

News and Trends 13 May 2016

First and only antibody for Multiple Myeloma approved in EU

Bristol-Myers Squibb and AbbVie have announced that their co-development project for an antibody therapy against Multiple Myeloma has been approved in the EU after a successful Phase III trial. Empliciti (elotuzumab) has been developed for the treatment of multiple myeloma as combination therapy in patients who have received at least one prior therapy, now making it […]

May 13, 2016 - 3 minutesmins - By Dani Bancroft

avexxin header biotech week

News and Trends 13 May 2016

Biotech of the Week: Avexxin, reducing inflammatory diseases from far up in Norway

We’re not going particularly far this week and we aren’t even leaving Scandinavia! From Stockholm, we are crossing the border to Norway and go up North. Sadly it’s not the see the Northern Lights but to visit Trondheim, where Avexxin, our Biotech of the Week is located. City: Trondheim (Norway) Founded: 2005 Employees: 8 (as of […]

May 13, 2016 - 1 minutemin - By Joachim Eeckhout

adenoviral lentiviral cell lines gene therapy cevec aav cap rca free biotech

News and Trends 12 May 2016

German Biotech achieves next step for Gene Therapy production of Viral Vectors

Cologne based Cevec specialises in producing tailor-made recombinant glycoproteins and gene therapy vectors. Now it has announced a breakthrough in their adenoviral vectors used in Gene Therapy. The increasing number of gene therapy-based discovery programs in the biotech and pharma industry is driving a greater need for the scalable production of gene therapy vectors. Vectors are needed […]

May 12, 2016 - 2 minutesmins - By Dani Bancroft

dresden spermbot sperm nanotechnology biotech IFW

News and Trends 12 May 2016

Sperm Cells Enlisted as Nanobot Delivery Guys

Reserchears at IFW Dresden were trying to create a nanorobot for drug delivery and even gene manipulation. They ended up using one of the motors created by nature – the flagella of sperm cells. Drug delivery is a key part in the development of new drugs, and an active field of research with academy-industry partnerships. Examples of ideas […]

May 12, 2016 - 3 minutesmins - By Denise Neves Gameiro

oxstem regenerative medicine stem cell leukemia

News and Trends 12 May 2016

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

OxStem’s strategy for stem cells therapy inside the body could have a big impact in regenerative medicine – and it has raised €21.4M, a record for a UK spin-out. A spin-out of Oxford University, OxStem is developing cell programming therapies that could treat a range of usually age-related conditions – dementia, heart failure, macular degeneration, […]

May 12, 2016 - 2 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT

technical university munich tum catalysis synbio

News and Trends 11 May 2016

Artificial enzymes to be developed in Munich with new Synbio Programme

Biological systems that could produce insulin out of greenhouse gas – this is one of the goals of the new €11.5M Synthetic Biology programme, at the Technical University of Munich (TUM). The Technical University of Munich (TUM) has many research highlights, including CAR-T research with impressive results. It has recently created the TUM School of Bioengineering […]

May 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

biotech nathalie moll europabio biotechnology

News and Trends 11 May 2016

EuropaBio: “We as an industry should be proud of what we do”

We just partnered with the European Biotech Week, which is a good reason to talk to its secretary general, Nathalie Moll. I asked her more about the event, the reasons for organising it and her vision for the future of Biotech in Europe. The event is a week of Biotech related seminars and activities from September 26th to October 2nd organised by […]

May 11, 2016 - 4 minutesmins - By Philip Hemme

bayer biontech veterinary mrna vaccine

News and Trends 11 May 2016

German mRNA specialist moves into Animal Health in collaboration with Bayer

BioNTech is joining its mRNA technology with Bayer’s expertise in veterinary applications in a new collaboration – to develop first-in-class vaccines for animals. Based in Mainz (Germany), BioNTech is the largest private Biotech in Europe. Along with its CAR-T and TCR programmes, BioNTech is developing mRNA therapies – a promising field in medicine. These include immunotherapies for […]

May 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

Neovacs lupus erythmatosis kinoid cytokine world day biotech therapy

News and Trends 10 May 2016

Today is World Lupus Day! Meet the people who are fighting this Rare disease

World Lupus Day is an initiative to increase the awareness around this disease which affects more than 5 million people worldwide. Last week in Paris, the biotech company Neovacs, which develops an innovative therapy against lupus, had gathered researchers, entrepreneurs and patients’ associations who are fighting the disease. I was there to meet them and […]

May 10, 2016 - 6 minutesmins - By Joachim Eeckhout

mvm capital mvm iv vc life sciences

News and Trends 10 May 2016

Life Sciences VC gets €204M in its Biggest Fundraiser Ever

MVM Capital has raised its fourth and largest funding round. It now has an additional €204M to invest in healthcare in the US and Europe. With offices in Boston and London, MVM Capital is an important VC in the healthcare sector – from biotechnology to medical devices. Its biggest success story is perhaps Heptares, a […]

May 10, 2016 - 2 minutesmins - By Denise Neves Gameiro

ergomed clinical trial smo operation andrew mackie drug development pipeline oncology autoimmune rare disease smo

News and Trends 10 May 2016

This UK Company told us how they Optimise Drug Development and turn a Profit

Drug development is complex, requiring a high level of many different skills as well as an insane amount of cash to put it on the market. Having an innovative business model can be one solution to make it affordable. That is what Ergomed, a profitable UK company is doing: combining Clinical Research Organisation (CRO) services and […]

May 10, 2016 - 4 minutesmins - By Dani Bancroft

ADVERTISEMENT